[Effect of intensive chemotherapy on bacterial excretion in fibrocavernous pulmonary tuberculosis]. 1979

I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 2004, Problemy tuberkuleza i boleznei legkikh,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
July 1980, Problemy tuberkuleza,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
February 1970, Praxis der Pneumologie,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 2005, Arkhiv patologii,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 1959, Suvremenna meditsina,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 1986, Indian journal of pediatrics,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
August 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 2003, Problemy tuberkuleza,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
May 1980, Vestnik khirurgii imeni I. I. Grekova,
I M Bondarev, and V Ia Sagalovich, and S S Kanevskaia, and V I Sharapova
January 1976, Problemy tuberkuleza,
Copied contents to your clipboard!